Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy

Behavioural Brain Research

Volumn 138, Issue 1, 2003, Pages 9-15

  Hozumi, Soichi ^a   Nakagawasai, Osamu ^a   Tan No, Koichi ^a   Niijima, Fukie ^a   Yamadera, Fumihiro ^a   Murata, Atsunobu ^a   Arai, Yuichiro ^b   Yasuhara, Hajime ^b   Tadano, Takeshi ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

Choline acetyltransferase; Elevated plus maze task; Immunohistochemistry; Impairment of learning and memory; Olfactory bulbectomy; Passive avoidance task

Indexed keywords

[4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; CHOLINE ACETYLTRANSFERASE; CHOLINESTERASE INHIBITOR; LOBELINE; METHOCTRAMINE; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR AGONIST; MUSCARINIC M2 RECEPTOR ANTAGONIST; NICOTINIC AGENT; OXOTREMORINE DERIVATIVE; OXOTREMORINE SESUQUIFUMARATE; PHYSOSTIGMINE; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHOLINERGIC SYSTEM; CONTROLLED STUDY; FLUORESCENCE; HIPPOCAMPUS; INTERMETHOD COMPARISON; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; MENTAL FUNCTION; MENTAL TASK; MOUSE; NONHUMAN; OLFACTORY BULBECTOMY; PASSIVE AVOIDANCE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

AMYGDALA; ANIMALS; AVOIDANCE LEARNING; CEREBRAL CORTEX; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; HIPPOCAMPUS; MALE; MAZE LEARNING; MICE; MICE, INBRED STRAINS; MICROSCOPY, FLUORESCENCE; NERVE NET; OLFACTORY BULB; RECEPTOR, MUSCARINIC M1; RECEPTORS, MUSCARINIC;

EID: 0037421098     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(02)00183-3     Document Type: Article

References (31)

1. Aura J., Sirvio J., Riekkinen P. Jr. Methoctramine moderately improves memory but pirenzepine disrupts performance in delayed non-matching to position test. Eur. J. Pharmacol. 333:1997;129-134.
2. 1 agonist improves cognitive performance in rats. Pharmacol. Biochem. Behav. 51:1995;667-674.
3. Bobkova N.V., Nesterova I.V., Nesterov V.V. The state of cholinergic structures in forebrain of bulbectomized mice. Bull. Exp. Biol. Med. 131:2001;427-431.
4. Broekkamp C.L., O'Connor W.T., Tonnaer J.A., Rijk H.W., VanDelft A.M. Corticosterone, choline acetyltransferase and noradrenaline levels in olfactory bulbectomized rats in relation to changes in passive avoidance acquisition and open field activity. Physiol. Behav. 37:1986;429-434.
5. Cain D.P. The role of the olfactory bulb in limbic mechanisms. Psychol. Bull. 81:1974;654-671.
6. Corwin J., Serby M., Conrad P., Rotrosen J. Olfactory recognition deficit in Alzheimer's disease and Parkinsonian dementias. IRCS Med. Sci. 13:1985;260.
7. Earley B., Glennon M., Lally M., Leonard B.E., Junien J.L. Autoradiographic distribution of cholinergic muscurinic receptors and serotonin (2) receptors in olfactory bulbectomized (OB) rats after chronic treatment with mianserin and desipramine. Hum. Psychopharmacol. 9:1994;397-407.
8. Esiri M.M., Wilcock G.K. The olfactory bulbs in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 47:1984;56-60.
9. Hall R.D., Macrides F. Olfactory bulbectomy impairs the rat's radial maze behavior. Physiol. Behav. 30:1983;797-803.
10. Hlinak Z., Krejci I. Concurrent administration of subeffective doses of scopolamine and MK-801 produces a short-term amnesia for the elevated plus-maze in mice. Behav. Brain Res. 91:1998;83-89.
11. Itoh J., Nabeshima T., Kameyama T. Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology. 101:1990;27-33.
12. Koss E. Olfactory dysfunction in Alzheimer's disease. Dev. Neuropsychol. 2:1986;89-99.
13. Kovacs T., Cairns N.J., Lantos P.L. Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stage. Neuroreport. 12:2001;285-288.
14. Larsson K. Impaired mating performances in male rats anosmia induced peripherally or centrally. Brain Behav. Evol. 4:1971;463-471.
15. Lumia A.R., Teicher M.H., Salchli F., Ayers E., Possidente B. Olfactory bulbectomy as a model for agitated hyposerotonergic depression. Brain Res. 587:1992;181-185.
16. Nakagawasai O., Tadano T., Hozumi S., Taniguchi R., Yamadera F., Tan-No K., Niijima F., Arai Y., Yasuhara H., Kinemuchi H., Kisara K. Involvement of muscarinic receptor on the impairment of avoidance learning in mice fed a thiamine-deficient diet. Biogenic Amines. 16:2001;199-210.
17. Nakagawasai O., Tadano T., Hozumi S., Tan-No K., Niijima F., Kisara K. Immunohistochemical estimation of brain choline acetyltransferase and somatostatin related to the impairment of avoidance learning induced by thiamine deficiency. Brain Res. Bull. 52:2000;189-196.
18. Nakagawasai O., Tadano T., Niijima F., Tan-No K., Kisara K. Immunohistochemical estimation of rat brain somatostatin on avoidance learning impairment induced by thiamine deficiency. Brain Res. Bull. 51:2000;47-55.
19. 2 receptor antagonist, improves cognitive performance following traumatic brain injury in rats. Brain Res. 686:1995;37-43.
20. Redmond A.M., Kelly J.P., Leonard B.E. Effect of paroxetine and fluvoxamine on behavioural changes in a number of paradigms in the olfactory bulbectomy. J. Serotonin Res. 1:1994;199-205.
21. Sakurada T., Kisara K. Effect of p-CPA on sleep in olfactory bulb lesioned rats. Jpn. J. Pharmacol. 27:1977;389-395.
22. Sakurada T., Shima K., Tadano T., Sakurada S., Kisara K. Sleep wakefulness rhythms in the olfactory bulb lesioned rat. Jpn. J. Pharmacol. 26:1976;605-610.
23. Serby M., Corwin J., Conrad P., Rotrosen R.P. Olfactory dysfunction in Alzheimer's disease and Parkinson's disease. Am. J. Psychiatry. 142:1985;781-782.
24. Sieck M.H. The role of the olfactory system in avoidance learning and activity. Physiol. Behav. 8:1972;705-710.
25. Simpson J., Yates C.M., Gordon A., St Clair D.M. Olfactory tubercle choline acetyltransferase activity in Alzheimer-type dementia, Down's syndrome and Huntington's chorea. J. Neurol. Neurosurg. Psychiatry. 47:1984;1138-1139.
26. Sutoo D., Akiyama K., Yabe K., Nishida N. Quantitative immunohistochemical distribution of choline acetyltransferase in the rostral forebrain of the rats. Neurosci. Res. 11:1991;63-70.
27. Thorne B.M., Aaron M., Latham E.E. Effect of olfactory bulb ablation upon emotionality and muricidal behavior in four rat strains. J. Comp. Physiol. Psychol. 34:1973;339-344.
28. Ukai M., Shinkai N., Kameyama T. Cholinergic receptor agonists inhibit pirenzepine-induced dysfunction of spontaneous alternation performance in the mouse. Gen. Pharmacol. 26:1995;1529-1532.
29. 1 agonist, enhanced spatial learning in C57BL/10 mice with a long duration of action. Brain Res. 597:1992;264-268.
30. Warner M.D., Peabody C.A., Flattery J.J., Tinklenberg J.R. Olfactory deficits and Alzheimer's disease. Biol. Psychiatry. 2:1986;116-118.
31. Yamamoto T., Jin J., Watanabe S. Characteristics of memory dysfunction in olfactory bulbectomized rats and the effects of cholinergic drugs. Behav. Brain Res. 83:1997;57-62.